Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 10,000 SPRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 10,000 | n/a |
| May 20, 2026 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 55,150 | n/a |
| Mar 2, 2026 | Larimar Therapeutics, Inc. (LRMR) | Purchase | 5,000 | $25.0K |
| Jun 17, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| May 14, 2025 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 19,000 | n/a |
| May 31, 2024 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 19,000 | n/a |
| May 30, 2024 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| Feb 15, 2024 | Larimar Therapeutics, Inc. (LRMR) | Purchase | 2,000 | $22.0K |
| Jan 24, 2024 | Orchard Therapeutics plc (ORTX) | Disposition to Issuer | 92,081 | n/a |
| Oct 10, 2023 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |